Tag: CTLA4

Prophylactic platelet transfusions prevent bleeding in hematologic cancers

Nivolumab/Ipilimumab vs Nivolumab Alone in Advanced Cancers Other Than Melanoma

byDaniel Goldshteinand1 others

September 11, 2023

1. Pooled overall survival and progression-free survival HR were found to be 0.95 and 0.88 for nivolumab/ipilimumab vs. nivolumab. 2. ...

Cervical cancer screening practices less cost-effective than suggested guidelines

Bastilimab plus zalifrelimab showed promising clinical and safety response for the treatment of refractory cervical cancer

byJamie Parkand1 others

January 10, 2022

1. The overall response rate (ORR) was 25.6%, with 8.0% of the patients achieved complete response. 2. Common treatment-related adverse ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result